Bristol-Myers Squibb Co. (BMY)
Current
- (-)
After Hours
Rating Performance
Rating Return
+0.0% vs
Rating Accuracy
0% (0 of 0*)
Rating Return
+0.0% vs
Rating Accuracy
0% (0 of 0*)
Rating Return
+0.0% vs
Rating Accuracy
0% (0 of 0*)
Rating Return
+0.0% vs
Rating Accuracy
0% (0 of 0*)
FV Performance
FV Accuracy
0 Hits (0% Hit Rate)
FV Avg. Distance
-9.7%
FV Accuracy
0 Hits (0% Hit Rate)
FV Avg. Distance
-8.88%
FV Accuracy
0 Hits (0% Hit Rate)
FV Avg. Distance
-8.88%
FV Accuracy
1 Hit (2.33% Hit Rate)
FV Avg. Distance
+3.32%
About
CEO
Giovanni Caforio
Employees
30,000
Industry
Oncology Biopharmaceuticals
Sector
Healthcare
Headquarters
New York
Exchange
New York Stock Exchange
Website
http://www.bms.comSummary Stats
Market Cap
155B
Revenue
46.7B
Net Income
6.68B
EPS
$3.08
Price-to-Earnings
23.63
Price-to-Book
4.74
Debt-to-Equity
2.01
News
Analyst Ratings
Price targets projected by 16 analysts
High
$88.00
Average
$74.06
Low
$64.00
Ratings calculated by 20 analysts
Buy
14
Hold
6
Sell
0
Last Dividend
Amount
$0.57
Dividend Date
Frequency
quarterly
Dividend Yield
Earnings
Most Recent Earnings
Last Earnings for Q4 2022
Above by $0.10
$1.82 +5.8%
1.72
1.83
Up 0%
Actual vs Estimates
XX
xxx
Upcoming Estimates Unavailable
-
-
-
--